Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
Journal of the International AIDS Society
|
February 18, 2020
Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics
Austin Tucker, Tannia Tembo, Radhika P Tampi, et al.
Plos One
|
September 24, 2009
An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia
Yanina Balabanova, Francis Drobniewski, Vladyslav Nikolayevskyy, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 6, 2022
Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda
Ryan R Thompson, Alex Kityamuwesi, Alice Kuan, et al.
The Lancet. Global Health
|
May 18, 2019
Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation
Anil Pooran, Grant Theron, Lynn Zijenah, et al.
Plos One
|
August 13, 2013
Cost-effectiveness comparison of Genechip and conventional drug susceptibility test for detecting multidrug-resistant tuberculosis in China
Yu Pang, Qiang Li, Xichao Ou, et al.
Chest
|
March 20, 2015
The Feasibility, Accuracy, and Impact of Xpert MTB/RIF Testing in a Remote Aboriginal Community in Canada
Gonzalo G Alvarez, Deborah D Van Dyk, Marc Desjardlns, et al.
PLOS Global Public Health
|
March 24, 2023
A controlled study to assess the effects of a Fast Track (FT) service delivery model among stable HIV patients in Lusaka Zambia
Carolyn Bolton Moore, Jake M Pry, Mpande Mukumbwa-Mwenechanya, et al.
Epidemiology and Health
|
December 19, 2025
Cohort profile: the KDCA-Tuberculosis-NHIS cohort linking tuberculosis surveillance and health insurance data in Korea
Dawoon Jeong, Jinsun Kim, Seung Won Lee, et al.
BMJ Global Health
|
January 7, 2022
Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis
Christiaan Mulder, Stephan Rupert, Ery Setiawan, et al.
JAMA Network Open
|
November 12, 2025
Long-Term Health and Cost Outcomes of a 24-Week Multicomponent Frailty Intervention in Older Adults
Sunghwan Ji, Jihye Lim, Tai Joon An, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
Journal of the International AIDS Society
|
February 18, 2020
Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics
Austin Tucker, Tannia Tembo, Radhika P Tampi, et al.
Plos One
|
September 24, 2009
An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia
Yanina Balabanova, Francis Drobniewski, Vladyslav Nikolayevskyy, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 6, 2022
Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda
Ryan R Thompson, Alex Kityamuwesi, Alice Kuan, et al.
The Lancet. Global Health
|
May 18, 2019
Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation
Anil Pooran, Grant Theron, Lynn Zijenah, et al.
Plos One
|
August 13, 2013
Cost-effectiveness comparison of Genechip and conventional drug susceptibility test for detecting multidrug-resistant tuberculosis in China
Yu Pang, Qiang Li, Xichao Ou, et al.
Chest
|
March 20, 2015
The Feasibility, Accuracy, and Impact of Xpert MTB/RIF Testing in a Remote Aboriginal Community in Canada
Gonzalo G Alvarez, Deborah D Van Dyk, Marc Desjardlns, et al.
PLOS Global Public Health
|
March 24, 2023
A controlled study to assess the effects of a Fast Track (FT) service delivery model among stable HIV patients in Lusaka Zambia
Carolyn Bolton Moore, Jake M Pry, Mpande Mukumbwa-Mwenechanya, et al.
Epidemiology and Health
|
December 19, 2025
Cohort profile: the KDCA-Tuberculosis-NHIS cohort linking tuberculosis surveillance and health insurance data in Korea
Dawoon Jeong, Jinsun Kim, Seung Won Lee, et al.
BMJ Global Health
|
January 7, 2022
Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis
Christiaan Mulder, Stephan Rupert, Ery Setiawan, et al.
JAMA Network Open
|
November 12, 2025
Long-Term Health and Cost Outcomes of a 24-Week Multicomponent Frailty Intervention in Older Adults
Sunghwan Ji, Jihye Lim, Tai Joon An, et al.
Page
of 7